A new institution for regenerative medicine.

Aeternus Sol was founded by surgeons and biotechnologists who repeatedly encountered the same wall: brilliant biology that could not survive the operating room. The gap between cellular science and clinical reality demanded a new kind of company — one that treats organs, instruments, and algorithms as a single integrated stack.

From our base in Antalya Teknokent, we are building proprietary perfusion platforms, cellular and exosome therapeutics, and an AI layer that lives between the surgeon and the tissue. Our work is rigorous, regulated, and quietly ambitious.

We are engineering a future in which organ failure is bridged, regeneration is routine, and surgery becomes restorative by default.